Age-Adjusted Serum Neurofilament Predicts Cognitive Decline in Parkinson's Disease (MARK-PD)

Mov Disord. 2022 Feb;37(2):435-436. doi: 10.1002/mds.28909. Epub 2022 Jan 17.

Authors

Carsten Buhmann¹, Susanne Lezius², Monika Pötter-Nerger¹, Christian Gerloff¹, Jens Kuhle³, Chi-Un Choe¹

Affiliations

¹ Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
² Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
³ Departments of Biomedicine and Clinical Research, Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.

PMID: 35040209
DOI: 10.1002/mds.28909

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Cognitive Dysfunction* / blood
Cognitive Dysfunction* / etiology
Humans
Intermediate Filaments
Neurofilament Proteins
Parkinson Disease* / blood
Parkinson Disease* / complications

Substances

Neurofilament Proteins